Review: Therapeutic Targeting of HMGB1 in Stroke

E-ISSN： 1875-5704|14|6|785-790

ISSN： 1567-2018

Source： Current Drug Delivery, Vol.14, Iss.6, 2017-09, pp. : 785-790

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

HMGB1-Directed Drug Discovery Targeting Cutaneous Inflammatory Dysregulation

Current Drug Metabolism, Vol. 11, Iss. 3, 2010-03 ,pp. : 250-265

Bentham Science Publishers

Access to resources Recommend Favorite

Non-histone nuclear factor HMGB1 as a therapeutic target in colorectal cancer

By Ohmori Hitoshi Luo Yi Kuniyasu Hiroki

Expert Opinion on Therapeutic Targets, Vol. 15, Iss. 2, 2011-02 ,pp. : 183-193

Informa Healthcare

Access to resources Recommend Favorite

Therapeutic Targeting of CD6 in Autoimmune Diseases: A Review of Cuban Clinical Studies with the Antibodies IOR-T1 and Itolizumab

Current Drug Targets, Vol. 17, Iss. 6, 2016-05 ,pp. : 666-677

Bentham Science Publishers

Access to resources Recommend Favorite

Evolving Therapeutic Targets in Ischemic Stroke: A Concise Review

Current Drug Targets, Vol. 14, Iss. 4, 2013-04 ,pp. : 497-506

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic targeting of B7-H1 in breast cancer

By Hasan Amal Ghebeh Hazem Lehe Cynthia Ahmad Rasheed Dermime Said

Expert Opinion on Therapeutic Targets, Vol. 15, Iss. 10, 2011-10 ,pp. : 1211-1225

Informa Healthcare

Access to resources Recommend Favorite